Rakieh, C., & Conaghan, P. G. (2014). Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis. Therapeutics & Clinical Risk Management, 10, 313. https://doi.org/10.2147/TCRM.S60740
Chicago Style (17th ed.) CitationRakieh, Chadi, and Philip G. Conaghan. "Comparative Clinical Utility of Once-weekly Subcutaneous Abatacept in the Management of Rheumatoid Arthritis." Therapeutics & Clinical Risk Management 10 (2014): 313. https://doi.org/10.2147/TCRM.S60740.
MLA (9th ed.) CitationRakieh, Chadi, and Philip G. Conaghan. "Comparative Clinical Utility of Once-weekly Subcutaneous Abatacept in the Management of Rheumatoid Arthritis." Therapeutics & Clinical Risk Management, vol. 10, 2014, p. 313, https://doi.org/10.2147/TCRM.S60740.